Comparison

CBR1 Antibody (C-term) Blocking Peptide

Item no. ABC-BP7563b
Manufacturer Abcepta
Amount 500 ug
Category
Type Peptides
Format Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Specific against other
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Similar products CBR1, CRN, CBR, Prostaglandin-E(2) 9-reductase, Carbonyl reductase [NADPH] 1, Prostaglandin 9-ketoreductase, 15-hydroxyprostaglandin dehydrogenase [NADP(+)], NADPH-dependent carbonyl reductase 1
Available
Primary Accession
P16152
Bio Background
Carbonyl reductase 1 (CBR1)is one of several monomeric, NADPH-dependent oxidoreductases having wide specificity for carbonyl compounds. This enzyme is widely distributed in human tissues.
Bio References
Colombe, L., Exp. Dermatol. 16 (9), 762-769 (2007)Lakhman, S.S., Mol. Pharmacol. 72 (3), 734-743 (2007)Gonzalez-Covarrubias, V., Drug Metab. Dispos. 35 (6), 973-980 (2007)
Gene ID
873
Gene Name
CBR1 (HGNC:1548)
Subtitle
Synthetic peptide
Target/Specificity
The synthetic peptide sequence used to generate the antibody AP7563b was selected from the C-term region of human CBR1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close